DK236185A - Stabiliseret insulin-formulering - Google Patents
Stabiliseret insulin-formulering Download PDFInfo
- Publication number
- DK236185A DK236185A DK236185A DK236185A DK236185A DK 236185 A DK236185 A DK 236185A DK 236185 A DK236185 A DK 236185A DK 236185 A DK236185 A DK 236185A DK 236185 A DK236185 A DK 236185A
- Authority
- DK
- Denmark
- Prior art keywords
- insulin formulation
- stabilized insulin
- stabilized
- formulation
- insulin
- Prior art date
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title 2
- 102000004877 Insulin Human genes 0.000 title 1
- 108090001061 Insulin Proteins 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 229940125396 insulin Drugs 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US61435584A | 1984-05-29 | 1984-05-29 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK236185D0 DK236185D0 (da) | 1985-05-28 |
| DK236185A true DK236185A (da) | 1985-11-30 |
Family
ID=24460897
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK236185A DK236185A (da) | 1984-05-29 | 1985-05-28 | Stabiliseret insulin-formulering |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0166529B1 (da) |
| JP (1) | JPS6122026A (da) |
| CA (1) | CA1244347A (da) |
| DE (1) | DE3576458D1 (da) |
| DK (1) | DK236185A (da) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0018609B1 (de) * | 1979-04-30 | 1983-09-21 | Hoechst Aktiengesellschaft | Gegen Denaturierung beständige, wässrige Protein-Lösungen, Verfahren zu ihrer Herstellung und ihre Verwendung |
| IL78425A (en) * | 1985-04-15 | 1991-05-12 | Lilly Co Eli | Intranasal formulation containing insulin |
| EP0211601A3 (en) * | 1985-07-30 | 1988-01-13 | International Minerals And Chemical Corporation | Stabilization of growth promoting hormones |
| JP3173794B2 (ja) * | 1994-05-20 | 2001-06-04 | 久光製薬株式会社 | タンパク質またはポリペプチド類とその製造法および中間化合物 |
| EP0803255A4 (en) * | 1994-06-03 | 1999-06-30 | Tsumura & Co | MEDICINAL COMPOSITION |
| FR2755440B1 (fr) * | 1996-11-07 | 1999-01-15 | Tuffet Sophie | Procede de conservation de longue duree de molecules d'adn et conditionnement pour sa mise en oeuvre |
| HU225770B1 (en) * | 1998-05-06 | 2007-08-28 | Sophie Tuffet | Method for prolonged storage of dna molecules and packaging implementing said method |
| DE10114178A1 (de) | 2001-03-23 | 2002-10-10 | Aventis Pharma Gmbh | Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität |
| DE10227232A1 (de) | 2002-06-18 | 2004-01-15 | Aventis Pharma Deutschland Gmbh | Saure Insulinzubereitungen mit verbesserter Stabilität |
| RS59913B1 (sr) | 2008-10-17 | 2020-03-31 | Sanofi Aventis Deutschland | Kombinacija insulina i glp-1-agonista |
| SG10201403840VA (en) | 2009-07-06 | 2014-10-30 | Sanofi Aventis Deutschland | Aqueous insulin preparations containing methionine |
| PL2498801T3 (pl) | 2009-11-13 | 2018-08-31 | Sanofi Aventis Deutschland | Kompozycja farmaceutyczna zawierająca desPro<sup>36</sup>eksendyno-4(1-39)-Lys6-NH2 i metioninę |
| SI2498802T1 (sl) | 2009-11-13 | 2015-05-29 | Sanofi-Aventis Deutschland Gmbh | Farmacevtski sestavek, ki vsebuje agonist GLP-1, inzulin in metionin |
| BR112013004756B1 (pt) | 2010-08-30 | 2020-04-28 | Sanofi Aventis Deutschland | uso de ave0010 para a fabricação de um medicamento para o tratamento da diabetes melito tipo 2 |
| US9821032B2 (en) | 2011-05-13 | 2017-11-21 | Sanofi-Aventis Deutschland Gmbh | Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin |
| CA2846413C (en) | 2011-08-29 | 2021-11-02 | Sanofi-Aventis Deutschland Gmbh | Pharmaceutical combination for use in glycemic control in diabetes type 2 patients |
| TWI559929B (en) | 2011-09-01 | 2016-12-01 | Sanofi Aventis Deutschland | Pharmaceutical composition for use in the treatment of a neurodegenerative disease |
| TWI758239B (zh) | 2014-12-12 | 2022-03-21 | 德商賽諾菲阿凡提斯德意志有限公司 | 甘精胰島素/利司那肽固定比率配製劑 |
| TWI748945B (zh) | 2015-03-13 | 2021-12-11 | 德商賽諾菲阿凡提斯德意志有限公司 | 第２型糖尿病病患治療 |
| TW201705975A (zh) | 2015-03-18 | 2017-02-16 | 賽諾菲阿凡提斯德意志有限公司 | 第２型糖尿病病患之治療 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0018609B1 (de) * | 1979-04-30 | 1983-09-21 | Hoechst Aktiengesellschaft | Gegen Denaturierung beständige, wässrige Protein-Lösungen, Verfahren zu ihrer Herstellung und ihre Verwendung |
| ZA808097B (en) * | 1980-12-29 | 1982-01-27 | Lilly Co Eli | Novel insulin formulations |
-
1985
- 1985-05-27 CA CA000482422A patent/CA1244347A/en not_active Expired
- 1985-05-28 DK DK236185A patent/DK236185A/da not_active Application Discontinuation
- 1985-05-28 DE DE8585303721T patent/DE3576458D1/de not_active Expired - Lifetime
- 1985-05-28 JP JP60115174A patent/JPS6122026A/ja active Pending
- 1985-05-28 EP EP19850303721 patent/EP0166529B1/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| CA1244347A (en) | 1988-11-08 |
| DE3576458D1 (de) | 1990-04-19 |
| JPS6122026A (ja) | 1986-01-30 |
| EP0166529A1 (en) | 1986-01-02 |
| EP0166529B1 (en) | 1990-03-14 |
| DK236185D0 (da) | 1985-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR8806982A (pt) | Composicao estabilizada | |
| BR8802017A (pt) | Composicao estabilizada | |
| NO2000005I1 (no) | Insulin aspart | |
| DK479685D0 (da) | Stol | |
| DK481585A (da) | Farmaceutisk praeparat indeholdende anthracyclinglycosider | |
| DK236185D0 (da) | Stabiliseret insulin-formulering | |
| DK162562C (da) | Staldkonstruktion | |
| IT1209615B (it) | Composizione farmaceutica | |
| DK437786D0 (da) | Insulinprecursorer | |
| DK86785D0 (da) | Bromcryptinpraeparater | |
| DK182287D0 (da) | Stabiliserede peptidsoedemidler | |
| MX163537B (es) | Composicion insecticida | |
| FR2582908B3 (fr) | Compositions stabilisees. | |
| ES288629Y (es) | Jeringa | |
| DK51885A (da) | Glycosylerede insulinderivater | |
| KR860007343U (ko) | 주사용 수액세트 | |
| ES276839Y (es) | Jeringuilla | |
| BR8406387A (pt) | Seringa | |
| IT8454191U1 (it) | Siringa di applicazione medico-veterinaria | |
| SE8402858D0 (sv) | Ampull | |
| SE8400444D0 (sv) | Ateranvendningsbart bodunderlag | |
| DK42483D0 (da) | Stabiliserede insulinoploesninger | |
| RO90654A2 (ro) | Compozitie insecticida sinergetica | |
| RO92144A2 (ro) | Compozitie insecticida | |
| LT2605B (lt) | Insekticidinis preparatas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ATS | Application withdrawn |